Market, reach, potential and growth of GMP laminins in NA
Reference number | |
Coordinator | BioLamina AB |
Funding from Vinnova | SEK 120 612 |
Project duration | June 2016 - December 2016 |
Status | Completed |
Purpose and goal
1) understand the market for clinical grade products better 2) identify customers in detail to understand their needs 3) make proper product pricing, offering and USPs All above achieved du to the detailed business plan conceived during this project.
Expected results and effects
BioLamina aims to enter the more potent clinical market space. With this project BioLamina has generated an executable business plan for the introduction of GMP laminins on the American market.
Planned approach and implementation
To assess the clinical market in the U.S, 155 primary research interviews were performed with current and potential customers, current and potential competitors, industry experts and employees to help inform the recommendations. In addition, secondary research was conducted which was substantiated with another round or interviews primarily with regulatory consultants.